Skip to main content

Table 2 Subjective assessment of presence of scar in the human subjects (Groups 1 and 2) and in the animals

From: Gray blood late gadolinium enhancement cardiovascular magnetic resonance for improved detection of myocardial scar

  LV scara Papillary muscle scara
  GB-LGE BB-LGE Conventional LGEb GB-LGE BB-LGE Conventional LGEb
Reader 1
 Group 1 9/18/0 9/17/1 6/19/2 14/13/0 12/15/0 10/17/0
 Group 2 8/10/0 n.a. 6/12/0 3/15/0 n.a. 3/15/0
 Animals 5/0/0 5/0/0 5/0/0 0/5/0 0/5/0 0/5/0
Reader 2
 Group 1 9/18/0 9/17/1 6/17/4 17/10/0 13/13/1 13/14/0
 Group 2 8/10/0 n.a. 7/11/0 3/15/0 n.a. 3/15/0
 Animals 5/0/0 5/0/0 5/0/0 0/5/0 0/5/0 0/5/0
  1. aData represent the number of cases scored as yes/no/uncertain regarding the presence of scar. Lack of BB-LGE data in group 2 is represented by ‘n.a.’ (i.e, not-available). GB gray blood, BB black blood, LGE late gadolinium enhancement
  2. bLGE (humans) or phase-sensitive LGE (animals)